Contact us Career

Nebulizers and Inhalers Market (Nebulizers (Ultrasonic Nebulizers [Pneumatic {Breath-Enhanced and Breath-Actuated}, Mesh Nebulizers [Active Mesh Nebulizers and Passive Mesh Nebulizers]) and Inhalers (Dry Powder Inhaler and Meter Dose Inhaler), End-users (Hospitals, Ambulatory Care Centers, and Home Care), and Regions (North America, Europe, Asia Pacific, and Rest of the World) - Global Forecast up to 2025

  • December, 2019
  • Domain: Healthcare - Medical Devices
Pages: 120
Tables: 50
Charts: 18
Regions/Countries: 4/0
Companies: 20+
Enquiry Hours: 10
  • Get Free 10% Customization in this Report

This market research report includes a detailed segmentation of the nebulizers and inhalers market – nebulizers (ultrasonic nebulizers [pneumatic {breath-enhanced and breath-actuated}, mesh nebulizers [active and passive mesh nebulizers]) and inhalers (dry powder inhaler and meter dose inhaler), end-users (hospitals, ambulatory care centers, and home care), and regions (North America, Europe, Asia Pacific, and Rest of the World).

Research Overview

Infoholic Research predicts that the global nebulizers and inhalers market will grow at a CAGR of 7.5% during the forecast period 2019–2025. The emergence of inhaled drug therapy could be more advantageous for patients with chronic respiratory conditions, such as COPD and asthma, due to its painless and flexible administration when compared to injections. The rising prevalence of chronic respiratory diseases is a significant factor fueling the growth of the market.

According to the global asthma report, asthma kills around 1000 people every day and affects as many as 339 million people, and prevalence is still rising, especially in low- and middle-income countries due to little awareness, which disproportionally witnesses the most severe cases. Also, lowered immunity among the geriatric population makes them more susceptible to pollution and infectious agents that cause respiratory disorders. According to the estimations by the Department of Economic and Social Affairs of the United Nations (UN DESA), the global population aged above 60 years was 962 million in 2017, which is projected to reach nearly 2.1 billion by 2050. Technological advancements with the development of an innovative solution in mesh nebulizers will drive the growth of the market in the future. Hospitals formed the largest end-user segment due to the availability of advanced medical equipment and well-educated medical professionals. North America has the largest market share due to a higher adaptation rate, a fast-moving lifestyle, and increasing respiratory incidents due to climate and pollution.

nebulizers inhalers market report

Besides, the increasing prevalence of respiratory diseases coupled with the rising demand for treatment measures is spurring the respiratory care devices market growth. Moreover, the presence of established infrastructure coupled with the availability of well-developed technologies that allow early implementation of advanced technology increases the size of the respiratory care devices market to an extent. Government initiatives toward improvising standard healthcare infrastructure and increased focus on healthcare expenditure are helping these countries to focus on offering high quality healthcare. Apart from this, Eastern European governments and respiratory care associations are working hard to promote the advanced respiratory treatments available in the market.

However, few of the manufacturing defects and low awareness are expected to affect the market growth. Also, the intense competition in the market alongside the cost associated with the device is expected to negatively impact on the market growth. Mergers & acquisitions are helping in geographical expansion. Many companies are adopting new features in their product portfolio to gain more attention in the market and open up opportunities to engage new patients. For instance, TOBI Podhaler by Novartis is portable and requires no nebulizer, refrigeration, or power source to deliver the medicine and is the first and only dry powder inhaled antibacterial in the US approved by FDA.

Increasing demand for nebulizers and inhalers with innovative features and better patience compliance is creating awareness among the population.

Segmentation by Product Type:

  • Nebulizers – ultrasonic, pneumatic (breath-enhanced and breath-actuated), and mesh nebulizers (active and passive mesh nebulizers)
  • Inhalers – dry powder inhaler and meter dose inhaler

Nebulizers are used to convert liquid medication into the mist to help in smooth inhalation deep into the respiratory system. This provides instant relief for asthma, cystic fibrosis, COPD, and many other respiratory conditions. Pneumatic nebulizers accounted for a maximum share in 2018, followed by mesh nebulizers.

The inhaler segment has negligible market share and is currently focusing more on smart inhalers and effective therapy for patients. Advancements in technology, especially digitalization and usage of apps & Bluetooth for easy access and monitoring have leveraged the demand for inhalers in the market.

Segmentation by End-users:

  • Hospitals
  • Ambulatory Care Centers
  • Home Care

In 2018, home care was leading with maximum revenue in the global nebulizers and inhalers market with large volumes of units being sold globally.

Segmentation by Region:

  • North America
  • EMEA
  • APAC
  • RoW

The regions covered in the report include North America, Europe, Asia Pacific, and Rest of the World. North America is set to be the leading region in the global nebulizers and inhalers market, followed by Europe. Asia Pacific and RoW are set to be the emerging regions. The emerging markets have a high potential to grow owing to an increase in the patient population and focus toward respiratory disorders. The global nebulizers and inhalers market is likely to seek a steady penetration rate in the emerging market, and most of the vendors are targeting to penetrate India, China, Thailand, and Vietnam markets. Further, driving factors such as large patient population and government initiatives have become a new trend in the emerging markets. According to WHO, India has an estimated 15–20 million asthmatics, and in 2016, it accounted for 10% of the global asthma patients. However, the high cost of nebulizers & inhalers, lack of proper reimbursement policies, and lack of awareness about advanced products in the developing countries will have a significant impact on the overall market growth.

Competitive Analysis – The competition among leading vendors is due to the availability of a wide range of nebulizers and inhalers with different brand names in the market. The market is highly competitive, with all the players competing to gain market stronghold. Intense competition, rapid advancements in technology, frequent changes in government policies, and fluctuating prices are the key factors that confront the market. The vendors have strong focus on understanding the customer base by creating awareness and initiatives to generate knowledge about their products and upcoming technologically advanced nebulizers and inhalers. The vendors have a strong focus on acquiring smaller companies and expanding their business operations by leveraging their product portfolio globally. The competition is growing among the healthcare service providers – hospitals, physicians’ clinics, and home care where the customer groups are being consolidated for adopting different nebulizers and inhalers. Most of the companies focus on developing products in less time and fasten the regulation process with effective means to commercialize the product early into the market to stay dominant.

Key Vendors:

  • Medtronic plc
  • Becton and Dickinson Company
  • GSK plc
  • AstraZeneca plc
  • Boehringer-Ingelheim
  • 3M
  • OMRON Corp.
  • PARI Medical Holdings GmbH
  • Philips Healthcare

Key Competitive Facts:

  • The market is highly competitive with all the players competing to gain the market share. Intense competition, rapid advancements in technology, frequent changes in government policies, and price are key factors that confront the market.
  • The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.
  • Responding to competitive pricing pressures specific to each of our geographic markets.
  • Protection of proprietary technology for products and manufacturing processes.

Benefits – The report provides complete details about the usage and adoption rate of nebulizer and inhaler products. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to stakeholders in order to expand their business and capture the revenue in specific verticals and to analyze before investing or expanding the business in this market.

Key Takeaways:

  • Understanding the potential market opportunity with precise market size and forecast data.
  • Detailed market analysis focusing on the growth of the nebulizer and inhaler products globally.
  • Factors influencing the growth of the nebulizer and inhaler products market.
  • In-depth competitive analysis of dominant and pureplay vendors.
  • Prediction analysis of the nebulizer and inhaler products industry across the globe.
  • Key insights related to major segments of the nebulizer and inhaler products market globally.
  • The latest market trend analysis impacting the buying behavior of the consumers.

nebulizers and inhalers market stakeholder

  1. Industry Outlook
    1. Industry Overview
    2. Geography   
    3. Industry Trends
    4. PEST Analysis
  2. Report Outline
    1. Report Scope
    2. Report Summary    
    3. Research Methodology       
    4. Report Assumptions
  3. Market Snapshot          
    1. Total Addressable Market  
    2. Segmented Addressable Market   
    3. Related Markets     
      1. Sleep Apnea  
      2. Anesthesia    
      3. Pulmonary Medicine 
  4. Market Outlook 
    1. Evolution of Nebulizers and Inhalers       
    2. Market Definition – Infoholic Research    
    3. Benefits of Nebulizers and Inhalers
    4. Features of Tabletop Nebulizers and Portable Nebulizers
    5. Features of Smart Inhalers 
    6. Market Segmentation        
    7. Porter 5(Five) Forces        
  5. Market Characteristics           
    1. Therapeutic Areas for Respiratory Disorders       
      1. Asthma        
      2. Chronic Obstructive Pulmonary Disease    
      3. Cystic Fibrosis
      4. Others
    2. Market Dynamics    
      1. Drivers         
        1. Rising prevalence of respiratory diseases  
        2. Favorable reimbursement   
        3. Rising geriatric population   
      2. Opportunities 
        1. Technological advancements
        2. Growing demand for home care therapeutic devices
      3. Restraints
        1. Stringent regulations for approval and mandatory licensing for practitioners
        2. Availability of alternatives   
    3. DRO – Impact Analysis      
    4. Key Stakeholders    
  6. Nebulizers: Market Size and Analysis        
    1. Overview     
    2. Ultrasonic Nebulizers         
    3. Pneumatic Nebulizers (Jet Nebulizers)     
      1. Breath-enhanced Jet Nebulizers     
      2. Breath-actuated Jet Nebulizers      
    4. Mesh Nebulizers     
      1. Active Mesh Nebulizers       
      2. Passive Mesh Nebulizers     
    5. Popular Drugs Used in Nebulizers  
  7. Inhalers: Market Size and Analysis 
    1. Overview     
    2. Dry Powder Inhaler 
    3. Meter Dose Inhaler 
    4. Popular Drugs Used in Inhalers     
  8. End-users: Market Size and Analysis          
    1. Overview     
    2. Hospitals      
    3. Ambulatory Care Centers   
    4. Home Care  
  9. Regions: Market Size and Analysis 
    1. Overview     
    2. North America        
      1. Overview      
      2. US     
      3. Canada        
    3. Europe        
      1. Overview      
      2. UK     
      3. Germany      
      4. France
    4. Asia Pacific  
      1. Overview      
      2. India  
      3. Japan 
      4. China 
    5. Rest of the World    
      1. Overview      
      2. Brazil 
      3. Mexico
  10. Competitive Landscape          
  11. Vendors Profile
    1. PLC
      1. Overview      
      2. Business Units         
      3. Geographic Revenue
      4. Business Focus        
      5. SWOT Analysis        
      6. Business Strategies  
    2. Becton Dickinson and Company     
      1. Overview      
      2. Business Units         
      3. Geographic Revenue
      4. Business Focus        
      5. SWOT Analysis        
      6. Business Strategies  
    3. GlaxoSmithKline       
      1. Overview      
      2. Geographic Revenue
      3. Business Focus        
      4. SWOT Analysis        
      5. Business Strategies  
    4. AstraZeneca  
      1. Overview      
      2. Geographic Revenue
      3. Business Focus
      4. SWOT Analysis
      5. Business Strategies
    5. Boehringer-Ingelheim
      1. Overview
      2. Geographic Revenue
      3. Business Focus
      4. SWOT Analysis
      5. Business Strategies
    6. 3M
      1. Overview
      2. Geographic Revenue
      3. Business Focus
      4. SWOT Analysis
      5. Business Strategies
    7. Omron Corp.
      1. Overview
      2. Geographic Revenue
      3. Business Focus
      4. SWOT Analysis
      5. Business Strategies
    8. PARI Medical Holding GmbH
      1. Overview      
      2. Business Focus
      3. SWOT Analysis
      4. Business Strategies
    9. Philips Healthcare
      1. Overview
      2. Business Units
      3. Geographic Revenue
      4. Business Focus
      5. SWOT Analysis
      6. Business Strategies
  12. Companies to Watch for
    1. Salter Labs, Inc.
      1. Overview
    2. Novartis       
      1. Overview
      2. Highlights
    3. Teva  
      1. Overview
      2. Highlights
    4. Adherium      
      1. Overview
      2. Highlights
    5. Inspiro Medical        
      1. Overview
      2. Highlights
    6. Cohero Health
      1. Overview
      2. Highlights
    7. Gecko Health Innovations, Inc.      
      1. Overview
      2. Highlights
    8. Drive DeVilbiss Healthcare Ltd.      
      1. Overview
      2. Highlights
    9. Nidek Medical India  
      1. Overview
    10. GF Health Products, Inc.
      1. Overview
      2. Highlights
    11. Allied Healthcare      
      1. Overview
      2. Highlights
    12. Agilent Technologies Inc.
      1. Overview



Research Framework

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

Market related information is congregated from both primary and secondary sources.

Primary sources

involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Interested in this report?
Get your FREE sample now!

Select User License


Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase